Chemical inhibitors of KV6.3 include a range of compounds that interfere with the protein's ability to conduct potassium ions across cellular membranes. Quinidine, for instance, can block KV6.3 by directly binding to its pore, obstructing the flow of potassium ions which is essential for the protein's conductance. Similarly, Amiodarone acts on KV6.3's inactivation gating mechanism, which results in a reduction of potassium efflux, essentially inhibiting the protein's function. Linopirdine also targets the channel pore of KV6.3, thereby impeding the flow of potassium ions and inhibiting the M-currents associated with neuronal activity modulated by KV6.3. Clofilium tosylate takes a different approach by binding to the open state of KV6.3, thus directly blocking potassium ion conductance through the channel.
Continuing with other inhibitors, Correolide can interact with the voltage sensor of KV6.3, which stabilizes the channel in its closed state and prevents it from opening, leading to inhibition. Dofetilide, by blocking the channel pore, impedes the flow of potassium ions through KV6.3, which is crucial for the protein's electrical signaling. Haloperidol, through its actions on the gating properties of KV6.3, can decrease potassium ion conductance. The compound 4-Aminopyridine inhibits KV6.3 by similarly blocking the channel pore, leading to a reduction in potassium ion flow and channel function. Tetraethylammonium serves as an inhibitor by obstructing the channel pore, disrupting normal potassium ion flow. XE991, by binding to the channel pore, prevents potassium ion conductance, which is vital for KV6.3 activity. Astemizole alters the voltage-sensing domain of KV6.3, which leads to decreased potassium efflux and subsequent inhibition of the protein. Riluzole can modulate the inactivation properties of KV6.3, reducing potassium ion conductance and thus inhibiting the channel activity. Each chemical, by altering the conductance or gating of KV6.3, provides a mechanistic insight into how the flow of potassium ions, which is integral to the function of KV6.3, can be inhibited.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Quinidine | 56-54-2 | sc-212614 | 10 g | $102.00 | 3 | |
Quinidine can block KV6.3 by binding to the pore of the channel, preventing the passage of potassium ions and thus inhibiting the channel's conductance. | ||||||
Amiodarone | 1951-25-3 | sc-480089 | 5 g | $312.00 | ||
Amiodarone inhibits KV6.3 by altering the channel's inactivation gating, leading to reduced potassium efflux and channel inhibition. | ||||||
Clofilium tosylate | 92953-10-1 | sc-391228 sc-391228A | 25 mg 100 mg | $428.00 $1020.00 | 1 | |
Clofilium tosylate inhibits KV6.3 by binding to the open state of the channel, thereby obstructing potassium ion conductance. | ||||||
Haloperidol | 52-86-8 | sc-507512 | 5 g | $190.00 | ||
Haloperidol can inhibit KV6.3 by altering the channel's gating properties, which results in a decrease in potassium ion conductance. | ||||||
4-Aminopyridine | 504-24-5 | sc-202421 sc-202421B sc-202421A | 25 g 1 kg 100 g | $37.00 $1132.00 $120.00 | 3 | |
4-Aminopyridine inhibits KV6.3 by blocking the channel pore, leading to reduced potassium ion flow and thereby inhibiting the channel's function. | ||||||
Riluzole | 1744-22-5 | sc-201081 sc-201081A sc-201081B sc-201081C | 20 mg 100 mg 1 g 25 g | $20.00 $189.00 $209.00 $311.00 | 1 | |
Riluzole can inhibit KV6.3 by modulating the channel's inactivation properties, thus reducing potassium ion conductance and inhibiting channel activity. | ||||||